Based on the analysis, S100B binds with strong affinity to the V-domain of the RAGE receptor. It can be utilized as both an adjunct marker, due to its lack of specificity, and as a prognostic marker, because its levels correlate with disease severity and patient outcomes across various neurological disorders.